BONESUPPORT Announces Positive Top-line data from the CERTiFy CERAMENT Study

BONESUPPORT announced that the CERTiFy study (CERAMENT® Treatment of Tibia Plateau Fracture defects) of CERAMENT bone void filler met its primary endpoint of non-inferiority to autologous iliac bone graft.

The prospective, multi-center, controlled trial enrolled 137 patients with fresh traumatic depression fractures of the proximal tibia at 20...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us